Ignite Creation Date:
2024-05-05 @ 9:53 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00004263
Status:
COMPLETED
Last Update Posted:
2012-07-30
First Post:
2000-01-28
Brief Title:
Cytarabine and UCN-01 in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Myelodysplastic Syndrome
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Myelodysplastic Syndromes |
| Leukemia |
Keywords:
| Name | View |
|---|---|
| UCN-01 | View |
| recurrent adult acute myeloid leukemia | View |
| refractory anemia with excess blasts | View |
| refractory anemia with excess blasts in transformation | View |
| previously treated myelodysplastic syndromes | View |
| childhood myelodysplastic syndromes | View |
| Ara-C | View |
| Cytosar | View |
| DepoCyt | View |
| Cytosine arabinosine hydrochloride | View |
| cytarabine | View |
| 7-hydroxystaurosporine | View |